Navigation Links
Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment
Date:9/10/2008

close of trading on December 31, 2008. Each common and series 'B' shareholder as of the record date will receive one series 'C' preferred share for each common share or series 'B' preferred share held. Each series 'C' preferred share will be convertible into common shares in the event the company attains a $100 million market capitalization. Thereafter, each series 'C' preferred shareholder may elect to convert each of his or her preferred shares into five common shares within the first six months of attaining the market capitalization milestone, seven and one-half common shares within the second six months, and ten common shares thereafter. Signalife will reserve the right in its sole discretion to convert all series 'C' preferred shares into common shares at the rate of one common share per preferred share, unless the $100 million market capitalization milestone has been attained, in which event the conversion rate will mirror the rate afforded to a voluntary conversion by the shareholder. The series 'C' preferred shares will have no voting, liquidation or dividend participation rights. The creation and distribution of the series 'C' preferred shares will be subject to applicable regulatory approvals.

According to Mr. Perkins, "This investment by ARC Finance Group and the company's directors in series 'B' preferred shares will ensure that Signalife has sufficient working capital to go forward and implement its sales and marketing plans and strategies over the near future. As will be demonstrated shortly, the F-100 has already saved lives and there are human beings walking around (as well as their physicians) who will demonstrate that without the F-100 they would have died. One of them is a 16-year old wrestler. I will announce the particulars when I determine in my discretion that the time is right. In this regard, considering that the F-100 is revolutionary and will save lives, the distribution of a dividend in series 'C' shares will reward shareholders w
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Signalife Announces Anticipated Date of Transition to OTCBB
2. Signalife to Issue Breaking News Regarding Vianale & Vianale Tomorrow
3. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
4. AFL To Return to Oklahoma Due to Overwhelming Demand for Signalife Heart Screening
5. Signalife Board Approves Merger
6. Signalife Announces AFL Joins NIH Education Program
7. Signalife Appoints Lee Ehrlichman President and Chief Operating Officer
8. Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders Equity Deficiency
9. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
10. Signalife Announces Webcast
11. AMEX Notifies Signalife That It Has Accepted Signalifes Plan of Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 02, 2015 Research and ... Jain PharmaBiotech,s new report "Gene Therapy - Technologies, ... The markets for gene therapy are difficult to estimate ... and it is marketed in China ... the years 2014-2024. The estimates are based on epidemiology ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... botanical and plant-derived compounds. BCC Research reveals in its new report that ... this market defines the category and generates the most market demand. , ...
(Date:9/2/2015)... , Sept. 2, 2015 Aytu BioScience, ... developing treatments for urological and related conditions, announced today ... planned private placement convertible note financing, raising a total ... tranches totaling $3.175 million. Josh ... from this private placement are intended to be used ...
(Date:9/2/2015)... September 2, 2015 BiondVax Pharmaceuticals Ltd. ... National Institute of Allergy and Infectious Diseases (NIAID), part of ... of Health and Human Services (HHS), to launch a new ... United States in the 2015-16 timeframe. The trial ... Multimeric-001 (M-001), as a primer vaccine, which would be administered ...
Breaking Biology Technology:Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... Life Sciences Industry in ... Western ... (PLSG), the organization providing capital investments and,customized company formation and ... the PLSG has reached a,significant milestone with over $10 million ...
... Huifeng,Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), ... and pharmaceutical raw materials,for use in pharmaceutical, ... will release financial results for their first ... 2008, after the US markets close.,Huifeng,s earnings ...
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), ... from Merz Pharmaceuticals GmbH (Merz) for sales,by ... for the treatment of,moderate-to-severe Alzheimer,s disease during ... exclusive marketing agreement, NTI currently receives,quarterly royalty ...
Cached Biology Technology:The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments 2The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments 3
(Date:8/24/2015)... Calif. , Aug. 24, 2015  Based on its ... recognizes DERMALOG with the 2015 African Biometrics Company of the ... has achieved substantial commercial success in Africa ... , where it has implemented one of the largest ... banks as well as the Central Bank of ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas ... key contributor to the Submission Content Management ... IRISS, a non-profit forum. Dedicated to the Implementation ... a neutral platform for industry, vendors, health ... information and work towards a standard method ...
(Date:8/12/2015)... , Aug. 12, 2015  New research ... can attack Android phones to steal users, fingerprints. ... increasing availability of fingerprint scanners on mobile devices, ... concern. To secure biometrics on mobile devices, HYPR ... augment these convenient authentication systems with strong cryptographic ...
Breaking Biology News(10 mins):Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3
... of the Blackleg fungus, which causes the most damaging disease ... time by a team of French and Australian scientists. ... University of Melbourne, who led the Australian research team, said ... Blackleg disease. "The 12,500 genes that constitute the genetic ...
... Optiqua Technologies Pte Ltd is collaborating with Nanyang ... in biomolecular sciences and sensor technology. Optiqua, ... provides the international water industry with innovative products ... detection of contaminants in water. The sensor technology ...
... , Scientists today agree that there are five molecules that ... an estimated five million Americans. The potency of these molecules ... Prof. Daniel Michaelson of Tel Aviv University,s Department ... Sciences has illuminating news about one of these five molecules ...
Cached Biology News:Uncovering the genome secrets of the Blackleg fungus 2Optiqua-NTU partnership to develop next-generation sensor technology 2Good diets fight bad Alzheimer's genes 2
... laboratories working in a regulated environment, ... pipette calibration software that automates gravimetric ... a framework that meets todays regulatory ... a secure solution that includes a ...
... Detection of the yolk protein Vtg in plasma ... and sensitive biomarker for endocrine disrupting chemicals (EDCs) ... has become an accepted screening test for the ... (rainbow trout) EIA kit is a double-antibody immunometric ...
... which no antibody exists? Having difficulty generating antibodies ... variety of pharmaceutical, biotech and academic researchers and ... and expertise in antibody generation to work for ... development technology , High affinity and high specificity ...
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
Biology Products: